Cardiff Lexington Corp
No SEC Form 4 filings for $CDIX in the last 30 days.
See all $CDIX insider activity →Cardiff Lexington Corp (CDIX) filed an SEC Form 8-K — Other Events. Exhibit 99.1 CARDIFF LEXINGTON CORPORATION ANNOUNCES LETTER OF INTENT FOR PROPOSED ACQUISITION OF LEADING MUSCULOSKELETAL HEALTHCARE PLATFORM Proposed Combination Would Significantly Expand Cardiff Lexington’s Musculoskeletal and Ancillary Healthcare Operations LEXINGTON, KY. — S
Cardiff Lexington Corporation (OTCQX:CDIX) filed its Form 10-Q for the quarter ended June 30, 2026. The company reported Q2 2026 revenue of $2.16M versus $2.79M in 2025, and a net loss of $2.48M. For six months, revenue fell to $4.38M and net loss was $5.57M. It cited working capital constraints and plans to evaluate debt restructuring and equity infusions.
Cardiff Lexington Corp (CDIX) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 2 cardiff_ex1001.htm COMMON STOCK PURCHASE AGREEMENT, DATED JUNE 5, 2026 Exhibit 10.1 COMMON STOCK PURCHASE AGREEMENT This COMMON STOCK PURCHASE AGREEMENT is made and entered into as of June 5, 2026 (this “ Agreement ”), by and among Leonite Fund I, LP (the “ Investor ”),
Over the past 7 days, AlphAI's AI scored 1 news story mentioning CDIX (Cardiff Lexington Corp). Coverage has skewed bullish: 1 bullish, 0 neutral, and 0 bearish.
Recent CDIX coverage spans corporate actions and earnings.
The proposed acquisition could significantly expand CDIX's operations and drive share price higher.
The filing and disclosed losses highlight ongoing liquidity and high-cost capital needs, increasing near-term financing and execution risk.
The filing discloses a potential equity issuance program (fixed purchase notices) tied to a minimum $0.20 trading price, which can pressure dilution and liquidity expectations.
AlphAI scores every news story that mentions CDIX with an AI model for sentiment and relevance, and aggregates insider trades from Cardiff Lexington Corp's SEC EDGAR Form 4 filings. Figures refresh continuously.
Cardiff Lexington Corp (CDIX) filed an SEC Form 8-K — Other Events. Exhibit 99.1 CARDIFF LEXINGTON CORPORATION ANNOUNCES LETTER OF INTENT FOR PROPOSED ACQUISITION OF LEADING MUSCULOSKELETAL HEALTHCARE PLATFORM Proposed Combination Would Significantly Expand Cardiff Lexington’s Musculoskeletal and Ancillary Healthcare Operations LEXINGTON, KY. — S
2 min readCardiff Lexington Corporation (OTCQX:CDIX) filed its Form 10-Q for the quarter ended June 30, 2026. The company reported Q2 2026 revenue of $2.16M versus $2.79M in 2025, and a net loss of $2.48M. For six months, revenue fell to $4.38M and net loss was $5.57M. It cited working capital constraints and plans to evaluate debt restructuring and equity infusions.
6 min readCardiff Lexington Corp (CDIX) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 2 cardiff_ex1001.htm COMMON STOCK PURCHASE AGREEMENT, DATED JUNE 5, 2026 Exhibit 10.1 COMMON STOCK PURCHASE AGREEMENT This COMMON STOCK PURCHASE AGREEMENT is made and entered into as of June 5, 2026 (this “ Agreement ”), by and among Leonite Fund I, LP (the “ Investor ”),
4 min read